Stocks
Applied Therapeutics (APLT) EBITDA margin US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| EBITDA margin, % | ? | -645.8% | -8 208% | |||||
| Changes by years, y/y, % | ||||||||
Applied Therapeutics. EBITDA margin, %
Applied Therapeutics. EBITDA margin, changes, pp
Applied Therapeutics (APLT) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | -3 150% | -11 101% | -14 194% | -24 294% | -8 208% | ||
| Changes by years, y/y, % | -10 995pp | |||||||
| Changes by quarters, q/q, % | -7 951pp | -3 093pp | -10 100pp | |||||
